Described is a process for making a dry and stable hemostatic composition said process comprising a) providing a dry granular preparation of a biocompatible polymer suitable for use in hemostasis b) coating the granules in said dry granular preparation with a preparation of a coagulation inducing agent thereby obtaining coagulation inducing agent coated polymer granules c) filling said coagulation inducing agent coated polymer granules into a final container d) finishing the final container to a storable pharmaceutical device containing said coagulation inducing agent coated polymer granules as a dry and stable hemostatic composition.
